Sheldon Hirt
Presidente presso EXINI DIAGNOSTICS AB
Profilo
Mr. Sheldon Hirt is a Senior Vice President & General Counsel at Orbia Advance Corp.
SAB de CV and a Chairman at EXINI Diagnostics AB.
He is on the Board of Directors at ei3 Corp.
Mr. Hirt was previously employed as an Executive Vice President & General Counsel by Progenics Pharmaceuticals, Inc. and a Secretary, Senior Vice President & General Counsel by Amneal Intermediate, Inc. He received his undergraduate degree from Columbia College (British Columbia), a graduate degree from Columbia Law School and a graduate degree from Columbia School of International & Public Affairs.
Posizioni attive di Sheldon Hirt
| Società | Posizione | Inizio |
|---|---|---|
| EXINI DIAGNOSTICS AB | Presidente | 01/07/2015 |
| ORBIA ADVANCE CORPORATION, S.A.B. DE C.V. | Consigliere Generale | 17/05/2019 |
ei3 Corp.
 ei3 Corp. Packaged SoftwareTechnology Services ei3 Corp. engages in the design and development of industrial machines. The company was founded by Spencer Cramer in 1999 and is headquartered in Pearl River, NY. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Sheldon Hirt
| Società | Posizione | Fine |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | Consigliere Generale | 02/09/2016 |
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Consigliere Generale | - |
Formazione di Sheldon Hirt
| Columbia College (British Columbia) | Undergraduate Degree |
| Columbia Law School | Graduate Degree |
| Columbia School of International & Public Affairs | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ORBIA ADVANCE CORPORATION, S.A.B. DE C.V. | Producer Manufacturing |
| Aziende private | 4 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
ei3 Corp.
ei3 Corp. Packaged SoftwareTechnology Services ei3 Corp. engages in the design and development of industrial machines. The company was founded by Spencer Cramer in 1999 and is headquartered in Pearl River, NY. | Technology Services |
EXINI Diagnostics AB
 EXINI Diagnostics AB Packaged SoftwareTechnology Services EXINI Diagnostics AB engages in the research, development, and operation of healthcare software solutions. The company was founded by Lars Edenbrandt, Carsten Peterson, and Karl Astrom on June 18, 1999 and is headquartered in Lund, Sweden. | Technology Services |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
- Borsa valori
- Insiders
- Sheldon Hirt
